Dimethyltryptamine molecule:

Image from PubChem

DMT Clinical Trials

A phase 2 clinical trial of GH001 in patients with postpartum depression

To see complete record on www.clinicaltrialsregister.eu, please visit this link

Id: 2021-006879-42

Organisation Name: GH Research Ireland Limited

Start Date: 2022-03-25

Completion Date: Ongoing

Brief Summary: To determine the onset and 7-day durability of anti-depressive effects of a single-day individualized dosing regimen of 6 mg, 12 mg and 18 mg of GH001 in adult, female patients with postpartum depression (PPD).

Country: Ireland

Total execution time in seconds: 0.094042062759399